Cargando…
Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA
SIMPLE SUMMARY: Monitoring chemical action of drugs directly at their molecular target would be particularly valuable for personalized medicine. In temozolomide-exposed biological samples, 2′-deoxyguanosines and O6-methylated species are compounds of interest to monitor chemical effects. However, th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913758/ https://www.ncbi.nlm.nih.gov/pubmed/36765673 http://dx.doi.org/10.3390/cancers15030716 |
_version_ | 1784885505009123328 |
---|---|
author | Fresnais, Margaux Jung, Ina Klein, Uli B. Miller, Aubry K. Turcan, Sevin Haefeli, Walter E. Burhenne, Jürgen Longuespée, Rémi |
author_facet | Fresnais, Margaux Jung, Ina Klein, Uli B. Miller, Aubry K. Turcan, Sevin Haefeli, Walter E. Burhenne, Jürgen Longuespée, Rémi |
author_sort | Fresnais, Margaux |
collection | PubMed |
description | SIMPLE SUMMARY: Monitoring chemical action of drugs directly at their molecular target would be particularly valuable for personalized medicine. In temozolomide-exposed biological samples, 2′-deoxyguanosines and O6-methylated species are compounds of interest to monitor chemical effects. However, their analysis can be hampered by molecular interferences. Hereby, desorption/ionization mass spectrometry was evaluated for such investigation. Here, we illustrate that, without following specific requirements in terms of sample preparation and mass spectrometric instrumentation, these analyses are prone to important artefacts. ABSTRACT: In clinical pharmacology, drug quantification is mainly performed from the circulation for pharmacokinetic purposes. Finely monitoring the chemical effect of drugs at their chemical sites of action for pharmacodynamics would have a major impact in several contexts of personalized medicine. Monitoring appropriate drug exposure is particularly challenging for alkylating drugs such as temozolomide (TMZ) because there is no flow equilibrium that would allow reliable conclusions to be drawn about the alkylation of the target site from plasma concentrations. During the treatment of glioblastoma, it appears, therefore, promising to directly monitor the alkylating effect of TMZ rather than plasma exposure, ideally at the site of action. Mass spectrometry (MS) is a method of choice for the quantification of methylated guanines and, more specifically, of O6-methylguanines as a marker of TMZ exposure at the site of action. Depending on the chosen strategy to analyze modified purines and 2′-deoxynucleosides, the analysis of methylated guanines and 2′-deoxyguanosines is prone to important artefacts due to the overlap between masses of (i) guanines from DNA and RNA, and (ii) different methylated species of guanines. Therefore, the specific analysis of O6-methyl-2′deoxyguanosine, which is the product of the TMZ effect, is highly challenging. In this work, we report observations from matrix-assisted laser desorption/ionization (MALDI), and desorption electrospray ionization (DESI) MS analyses. These allow for the construction of a decision tree to initiate studies using desorption/ionization MS for the analysis of 2′-deoxyguanosine methylations induced by TMZ. |
format | Online Article Text |
id | pubmed-9913758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99137582023-02-11 Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA Fresnais, Margaux Jung, Ina Klein, Uli B. Miller, Aubry K. Turcan, Sevin Haefeli, Walter E. Burhenne, Jürgen Longuespée, Rémi Cancers (Basel) Article SIMPLE SUMMARY: Monitoring chemical action of drugs directly at their molecular target would be particularly valuable for personalized medicine. In temozolomide-exposed biological samples, 2′-deoxyguanosines and O6-methylated species are compounds of interest to monitor chemical effects. However, their analysis can be hampered by molecular interferences. Hereby, desorption/ionization mass spectrometry was evaluated for such investigation. Here, we illustrate that, without following specific requirements in terms of sample preparation and mass spectrometric instrumentation, these analyses are prone to important artefacts. ABSTRACT: In clinical pharmacology, drug quantification is mainly performed from the circulation for pharmacokinetic purposes. Finely monitoring the chemical effect of drugs at their chemical sites of action for pharmacodynamics would have a major impact in several contexts of personalized medicine. Monitoring appropriate drug exposure is particularly challenging for alkylating drugs such as temozolomide (TMZ) because there is no flow equilibrium that would allow reliable conclusions to be drawn about the alkylation of the target site from plasma concentrations. During the treatment of glioblastoma, it appears, therefore, promising to directly monitor the alkylating effect of TMZ rather than plasma exposure, ideally at the site of action. Mass spectrometry (MS) is a method of choice for the quantification of methylated guanines and, more specifically, of O6-methylguanines as a marker of TMZ exposure at the site of action. Depending on the chosen strategy to analyze modified purines and 2′-deoxynucleosides, the analysis of methylated guanines and 2′-deoxyguanosines is prone to important artefacts due to the overlap between masses of (i) guanines from DNA and RNA, and (ii) different methylated species of guanines. Therefore, the specific analysis of O6-methyl-2′deoxyguanosine, which is the product of the TMZ effect, is highly challenging. In this work, we report observations from matrix-assisted laser desorption/ionization (MALDI), and desorption electrospray ionization (DESI) MS analyses. These allow for the construction of a decision tree to initiate studies using desorption/ionization MS for the analysis of 2′-deoxyguanosine methylations induced by TMZ. MDPI 2023-01-24 /pmc/articles/PMC9913758/ /pubmed/36765673 http://dx.doi.org/10.3390/cancers15030716 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fresnais, Margaux Jung, Ina Klein, Uli B. Miller, Aubry K. Turcan, Sevin Haefeli, Walter E. Burhenne, Jürgen Longuespée, Rémi Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA |
title | Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA |
title_full | Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA |
title_fullStr | Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA |
title_full_unstemmed | Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA |
title_short | Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA |
title_sort | important requirements for desorption/ionization mass spectrometric measurements of temozolomide-induced 2′-deoxyguanosine methylations in dna |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913758/ https://www.ncbi.nlm.nih.gov/pubmed/36765673 http://dx.doi.org/10.3390/cancers15030716 |
work_keys_str_mv | AT fresnaismargaux importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna AT jungina importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna AT kleinulib importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna AT milleraubryk importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna AT turcansevin importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna AT haefeliwaltere importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna AT burhennejurgen importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna AT longuespeeremi importantrequirementsfordesorptionionizationmassspectrometricmeasurementsoftemozolomideinduced2deoxyguanosinemethylationsindna |